LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Total assets, 2025
- $1.6B
- YoY, 2025
- +65.7%
- 5-year CAGR
- +2.8%
- 10-year CAGR
- +12.0%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $1.6B | +65.7% |
| 2024 | $942M | +19.6% |
| 2023 | $787M | +3.2% |
| 2022 | $763M | −41.2% |
| 2021 | $1.3B | −4.7% |
| 2020 | $1.4B | −8.9% |
| 2019 | $1.5B | +18.6% |
| 2018 | $1.3B | +87.9% |
| 2017 | $671M | +11.5% |
| 2016 | $602M | +19.6% |
| 2015 | $503M | +95.0% |
| 2014 | $258M | +146.4% |
| 2013 | $105M | +0.4% |
| 2012 | $104M | −13.5% |
| 2011 | $121M | +59.6% |
| 2010 | $76M | — |